Fig. 1.
Serologic evidence of primary and recurrent B19 infection in 8 BMT patients. Group A, seronegative recipients with seronegative donors; group B, seronegative recipients with seropositive donors; group C, seropositive recipients with seronegative donors; group D, seropositive recipients with seropositive donors. The dotted line gives the manufacturer's cutoff.